[go: up one dir, main page]

TR200200246T2 - Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim. - Google Patents

Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim.

Info

Publication number
TR200200246T2
TR200200246T2 TR2002/00246T TR200200246T TR200200246T2 TR 200200246 T2 TR200200246 T2 TR 200200246T2 TR 2002/00246 T TR2002/00246 T TR 2002/00246T TR 200200246 T TR200200246 T TR 200200246T TR 200200246 T2 TR200200246 T2 TR 200200246T2
Authority
TR
Turkey
Prior art keywords
treatment
flu
diseases
prevention
symptoms associated
Prior art date
Application number
TR2002/00246T
Other languages
English (en)
Turkish (tr)
Inventor
Seymour Gantenberg Nicholas
Robert Ernest Singer Jr.
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR200200246T2 publication Critical patent/TR200200246T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
TR2002/00246T 1999-07-30 2000-07-28 Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim. TR200200246T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36494499A 1999-07-30 1999-07-30

Publications (1)

Publication Number Publication Date
TR200200246T2 true TR200200246T2 (tr) 2002-09-23

Family

ID=23436803

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00246T TR200200246T2 (tr) 1999-07-30 2000-07-28 Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim.

Country Status (10)

Country Link
EP (1) EP1221949A2 (fr)
JP (1) JP2003505500A (fr)
CN (1) CN1377262A (fr)
AU (1) AU6240200A (fr)
CA (1) CA2379703A1 (fr)
CO (1) CO5200850A1 (fr)
HK (1) HK1049104A1 (fr)
PE (1) PE20010540A1 (fr)
TR (1) TR200200246T2 (fr)
WO (1) WO2001008671A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
ITRM20020562A1 (it) 2002-11-06 2004-05-07 Sigma Tau Ind Farmaceuti Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
RU2007132962A (ru) * 2005-02-04 2009-03-10 Петер ХЕГЕР (DE) Применение гидроксистильбенсодержащих активных веществ для профилактики и/или лечения остеопороза
ATE464890T1 (de) * 2006-03-28 2010-05-15 Epitech Group Srl Eine pharmazeutische zusammensetzung zur behandlung von pathologien, die durch die allgemeine immunantwort verursacht werden
CN100453071C (zh) * 2006-11-03 2009-01-21 李万忠 白藜芦醇口服多相脂质体及其制备方法
JPWO2008136173A1 (ja) * 2007-04-20 2010-07-29 国立大学法人お茶の水女子大学 スチルベン誘導体を有効成分とする脂肪細胞分化抑制剤
EP2231133A4 (fr) 2008-01-08 2014-08-20 David Rubin Compositions et procédé d'administration de resvératrol et de ptérostilbène
FR2933871B1 (fr) * 2008-07-18 2012-12-14 Yvery Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe
PL2544705T3 (pl) * 2010-03-12 2017-02-28 Synairgen Research Limited Interferon beta do zastosowania w leczeniu schorzenia dolnych dróg oddechowych powodowanego przez grypę
JP5848042B2 (ja) 2011-06-29 2016-01-27 株式会社ロッテ 眼疲労抑制組成物及びそれを含む飲食品
SG11201401570YA (en) * 2011-10-19 2014-05-29 Nad Life Pty Ltd Pharmaceutical compositions of resveratrol
CN106581028A (zh) * 2016-11-30 2017-04-26 南宁市浩特竹鼠养殖场 一种治疗竹鼠感冒的西药及其制备方法
US20230145555A1 (en) * 2020-04-10 2023-05-11 Galenus G.H. Ag Composition comprising resveratrol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753359A (ja) * 1993-06-11 1995-02-28 Kao Corp リポキシゲナーゼ阻害剤
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
AU4084599A (en) * 1998-05-18 1999-12-06 Oklahoma Medical Research Foundation Resveratrol inhibition of myeloperoxidase
US6197834B1 (en) * 1998-09-01 2001-03-06 Northeastern Ohio Universities College Of Medicine Method of inhibiting formation of infectious herpes virus particles
US6486203B1 (en) * 1998-09-08 2002-11-26 Cornell Research Foundation, Inc. Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors

Also Published As

Publication number Publication date
CN1377262A (zh) 2002-10-30
CA2379703A1 (fr) 2001-02-08
EP1221949A2 (fr) 2002-07-17
HK1049104A1 (zh) 2003-05-02
AU6240200A (en) 2001-02-19
PE20010540A1 (es) 2001-05-15
WO2001008671A3 (fr) 2002-05-02
WO2001008671A2 (fr) 2001-02-08
CO5200850A1 (es) 2002-09-27
JP2003505500A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
TR200200246T2 (tr) Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim.
MEP35308A (en) COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
DE60119534D1 (de) Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
ATE303156T1 (de) Verwendung von gnrh-analogue zur behandlung der harninkontinenz
PT1194049E (pt) Peca de vestuario com capacidade respiratoria, para ser vestida com o intuito de melhorar o conforto do corpo humana
TW200505434A (en) Therapeutic treatment
TR200000726T2 (tr) Budesonid ve formoterol'ün yeni kullanımı.
MY144616A (en) Substituted dihydroquinazolines
BRPI0411050A (pt) composições para prevenção e tratamento de sintomas semelhantes a gripe e resfriado compreendendo zinco quelado
ATE364595T1 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
EP1482959A4 (fr) Compositions et methodes de traitement de troubles cutanes
TR200001040T2 (tr) Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
TR200000157T2 (tr) Nitrik oksit rhinovirüsün bulaşmasını önler.
EE200200337A (et) Uued ühendid ning nende kasutamine
IL162600A0 (en) Cc-chemokine mutants as cc-chemokine antagonists
TR200003356T2 (tr) Kabergolin ve pramipeksol: yeni kullanım biçimleri ve birlikte kullanılmaları.
MXPA02011511A (es) USO DE (+)-alfa û(2,3-dimetoxifenil)etil-1-[2-(4-fluorofenil)etil] -4-piperidin metanol o sus fármacos en el tratamiento de síntomas demencia y psicosis inducida por dofamina.
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
NO20006699L (no) Forbindelser med veksthormonfrigjörende egenskaper
ZA9711468B (en) New use of comt inhibitors